Effects of OROS Methylphenidate on Academic,Behavioral,and Cognitive Tasks in Children 9 to 12 Years of Age With Attention-Deficit/Hyperactivity Disorder

Abstract

Objective. To assess effects of OROS methylphenidate on cognitive and academic tasks in 9 to 12 year olds with attention-deficit/hyperactivity disorder (ADHD). Methods. A double-blind, within-subject, crossover design was used to compare OROS methylphenidate with placebo in a laboratory classroom setting on several cognitive and academic tasks for 68 children who met randomization criteria. Results. Performance on the following measures was significantly better when children received individually optimized OROS methylphenidate than placebo: math fluency and accuracy measured by the Permanent Product Math Test, ADHD symptoms observed in the laboratory setting, computerized indices of attention and impulsivity as measured by the Test of Variables of Attention (TOVA), and visual—spatial working memory (Finger Windows Backwards). Study medication was well tolerated; adverse events were generally consistent with previous reports. Conclusions. OROS methylphenidate improves performance on measures of attention and vigilance, behavior, and working memory in a laboratory school setting in 9 to 12 year olds with ADHD.

Keywords

ADHD cognitive academic methylphenidate

Get full access to this article

View all access options for this article.

References

Barkley R. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull. 1997 ;121:65-94.

Pliszka SR , Glahn DC , Semrud-Clikeman M. , et al. Neuroimaging of inhibitory control areas in children with attention-deficit hyperactivity disorder who were treatment naïve or in long-term treatment . Am J Psychiatry. 2006;163:1052-1060.

Semrud-Clikeman M. , Pliszka SR , Lancaster J. , Liotti M. Volumetric MRI differences in treatment-naive vs chronically treated children with ADHD. Neurology. 2006;67: 1023-1027.

Willcutt EG , Doyle AE , Nigg JT , Faraone SV , Pennington BF Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry. 2005;57:1336-1346.

Martinussen R. , Hayden J. , Hogg-Johnson S. , Tannock R. A meta-analysis of working memory impairments in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2005;44:377-384.

Loe IM , Feldman HM Academic and educational outcomes of children with ADHD. J Pediatr Psychol. 2007;32:643-654.

Barkley RA , DuPaul GJ , McMurray MB Comprehensive evaluation of attention deficit disorder with and without hyperactivity as defined by research criteria. J Consult Clin Psychol. 1990;58:775-789.

Currie J. , Stabile M. Child mental health and human capital accumulation: the case of ADHD. J Health Econ. 2006;25:1094-1118.

Barkley RA , Fischer M. , Smallish L. , Fletcher K. Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry. 2006;45:192-202.

10.

Hinshaw SP Preadolescent girls with attention-deficit/ hyperactivity disorder: I. Background characteristics, comorbidity, cognitive and social functioning, and parenting practices. J Consult Clin Psychol. 2002;70:1086-1098.

11.

Mehta MA , Owen AM , Sahakian BJ , Mavaddat N. , Pickard JD , Robbins TW Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci. 2000;20:RC65.

12.

Pietrzak RH , Mollica CM , Maruff P. , Snyder PJ Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder. Neurosci Biobehav Rev. 2006;30:1225-1245.

13.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Text Revision. Washington, DC: American Psychiatric Association; 2000.

14.

Kaufman J. , Birmaher B. , Brent D. , et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (KSADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36:980-988.

15.

Wechsler D. Manual for the Wechsler Abbreviated Scale of Intelligence. San Antonio, TX: Psychological Corporation; 1999.

16.

Gray WE , Robinson HM Gray Oral Reading Test. Indianapolis, IN: Bobbs-Merrill ; 1967.

17.

Wagner RJ , Torgeson JK , Rashotte CA Comprehensive Test of Phonological Processing. Austin, TX: Pro-Ed; 1999.

18.

Wechsler D. Wechsler Individual Achievement Test. 2nd ed. San Antonio, TX: Psychological Corporation; 1992.

19.

Guy W. Clinical global impressions. In: Guy W , ed. ECDEU Assessment Manual for Psychopharmacology. Revised ed. Rockville, MD: National Institute of Mental Health; 1976:217-221.

20.

Swanson J. , Agler D. , Fineberg E. , et al. UCI laboratory school protocol for PK/PD studies. In: Greenhill LL , Osman BB , eds. Ritalin: Theory and Practice. Larchmont, NY: Mary Ann Liebert; 1999:405-430.

21.

Swanson J. , Gupta S. , Lam A. , et al. Development of a new once a day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2006;60:204-211.

22.

Wigal SB , Wigal TL The laboratory school protocol: its origin, use, and new applications. J Atten Disord. 2006;10:92-111.

23.

Swanson JM School-Based Assessments and Interventions for ADD Students. Irvine, CA: KC Publishing; 2002.

24.

Greenhill LL , Swanson JM , Steinhoff K. , et al. A pharmacokinetic/pharmacodynamic study comparing a single morning dose of adderall to twice-daily dosing in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2003;42:1234-1241.

25.

Wigal SB , Gupta S. , Guinta D. , Swanson JM Reliability and validity of the SKAMP rating scale in a laboratory school setting. Psychopharmacol Bull. 1998;34:47-53.

26.

Wada N. , Yamashita Y. , Matsuishi T. , Ohtani Y. , Kato H. The test of variables of attention (TOVA) is useful in the diagnosis of Japanese male children with attention deficit hyperactivity disorder. Brain Dev. 2000;22:378-382.

27.

Greenberg LM , Waldman ID Developmental normative data on the test of variables of attention (TOVA) . J Child Psychol Psychiatry. 1993;34:1019-1030.

28.

Huang YS , Chao CC , Wu YY , Chen YY , Chen CK Acute effects of methylphenidate on performance during the Test of Variables of Attention in children with attention deficit/hyperactivity disorder. Psychiatry Clin Neurosci. 2007;61:219-225.

29.

Manor I. , Meidad S. , Zalsman G. , Zemishlany Z. , Tyano S. , Weizman A. Objective versus subjective assessment of methylphenidate response. Child Psychiatry Hum Dev. 2008;39:273-282.

30.

Kaplan E. , Fein D. , Kramer J. , et al. WISC-III PI Manual. San Antonio, TX: Psychological Corporation; 1999.

31.

Adams W. , Sheslow D. WRAML Manual. Wilmington, DE: Jastak Associates; 1990.

32.

Wiederholt JL , Blalock G. Gray Silent Reading Tests: Examiner’s Manual. Austin, TX: Pro-Ed; 2000.

33.

Good RH , Kaminski RA Dynamic Indicators of Basic Early Literacy Skills. 6th ed. Eugene, OR: Institute for the Development of Educational Achievement; 2002.

34.

Hintze JM , Ryan AL , Stoner G. Concurrent validity and diagnostic accuracy of the Dynamic Indicators of Basic Early Literacy Skills and the Comprehensive Test of Phonological Processing . School Psych Rev. 2003;32:541-556.

35.

Milone M. Test of Handwriting Skills Revised Manual. Novato, CA: Academic Therapy Publications; 2007.

36.

Swanson J. , Gupta S. , Lam A. , et al. Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies. Arch Gen Psychiatry. 2003;60:204-211.

37.

Hochberg Y. , Tamhane AC Multiple Comparison Procedures. New York, NY: John Wiley; 1987.

38.

Dmitrienko A. , Tamhane AC Gatekeeping procedures with clinical trial applications. Pharm Stat. 2007;6:171-180.

39.

Leslie LK , Wolraich ML ADHD service use patterns in youth. J Pediatr Psychol. 2007;32;695-710.

40.

Bedard AC , Jain U. , Johnson SH , Tannock R. Effects of methylphenidate on working memory components: influence of measurement . J Child Psychol Psychiatry. 2007;48:872-880.

41.

42.

Barbaresi WJ , Katusic SK , Colligan RC , Weaver AL , Jacobsen SJ Modifiers of long-term school outcomes for children with attention-deficit/hyperactivity disorder: does treatment with stimulant medication make a difference? Results from a population-based study . J Dev Behav Pediatr. 2007;28:274-287.

43.

Powers RL , Marks DJ , Miller CJ , Newcorn JH , Halperin JM Stimulant treatment in children with attention-deficit/hyperactivity disorder moderates adolescent academic outcome. J Child Adolesc Psychopharmacol . 2008;18: 449-459.

44.

Semrud-Clikeman M. , Pliszka S. , Liotti M. Executive functioning in children with attention-deficit/hyperactivity disorder: combined type with and without a stimulant medication history. Neuropsychology. 2008;22:329-340.

45.

Scheffler RM , Brown TT , Fulton BD , Hinshaw SP , Levine P. , Stone S. Positive association between attention-deficit/ hyperactivity disorder medication use and academic achievement during elementary school. Pediatrics. 2009;123:1273-1279.

46.

Greenhill LL , Swanson JM , Vitiello B. , et al. Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. J Am Acad Child Adolesc Psychiatry. 2001;40:180-187.

47.

Steele M. , Jensen PS , Quinn DM Remission versus response as the goal of therapy in ADHD: a new standard for the field? Clin Ther. 2006;28:1892-1908.